GRYPHON BIO INC
Last verified 2026-05-06. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.2Mattributed |
|---|---|
| Latest round | grant, $1.2M, 2025-01-01attributed |
| Founded | unknown |
| Headquarters | San Antonio, Texas, USA |
| Industry | healthtech |
| Stage | unknown |
| Website | gryphonbio.com |
SBIR Phase II award from Department of Health and Human Services (National Institutes of Health): Development of Novel sgp130-Fc Bioconjugates for TBI
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | grant | $1.2M | undisclosed |
Detected tech stack
Google Cloud CDN, Sentry, Vercel Speed Insights, WebsiteBuilder, Wix, Google Cloud, React, lodash .
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.2M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.2M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | gryphonbio.com, read 2026-05-06 |
| Description | self-reported | gryphonbio.com, read 2026-05-06 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.